Caraco launches generic dementia treatment

Alaric DeArment

7/6/2010

DETROIT Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco said.

The drug maker began shipping rivastigmine tartrate capsules. The capsules are used to treat mild to moderate dementia in patients with Alzheimer’s disease and Parkinson’s disease.

The drug is a generic version of Novartis’ Exelon, which has annual sales of around $130 million, according to Caraco.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Sycamore Partners reportedly working on financing to acquire Walgreens

A potential buyout reportedly would include terms loans, a bridge loan and asset-based lending.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Walgreens reportedly close to roughly $10B deal to go private

The deal could be finalized by Thursday, per a WSJ report.